Join CTTC | Print Page | Contact Us | Sign In
Upcoming Webinars

CTTC presents a webinar series available for both CTTC members and non-members, on a variety of topics related to the field of hematopoietic stem cell transplant and cell therapy. 

CTTC Member Pricing: FREE access to all webinars in the 2020 Webinar Series
Non-Member Pricing: $90 + GST per webinar


To promote the CTTC 2020 Webinar Series in your centre, please download the CTTC 2020 Webinar Series poster.
 

The University of British Columbia Division of Continuing Professional Development (UBC CPD) is fully accredited by the Committee on Accreditation of Continuing Medical Education (CACME) to provide study credits for continuing medical education for physicians.  This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and has been approved by UBC CPD for up to 8.0 MOC Section 1 Group Learning credits.Each physician should claim only those credits he/she actually spent in the activity.


 

2020 Webinar Series

September 30, 2020
9:00am PT/12:00pm ET
CME Credit Hours: 1.0


Changing Landscape in Invasive Mold Infections in Haematological Patients

Shariq HaiderMD, FRCPC (McMaster University, Hamilton, ON)

Speaker Biography: 

Dr. Haider is Professor of Infectious Diseases in Department of Medicine, McMaster University. He is an Infectious Diseases and Internal Medicine Consultant at Hamilton Health Sciences. He is the past Program Director for McMaster Internal Medicine Residency Program. He has been involved in Infectious Diseases and HIV care for the past 20 years, and is the Current Medical Director of the SIS clinic in Hamilton. He is the Head of the Transplant/Malignant Infectious Diseases Service at the Juravinski Hospital and Cancer Center. His research interests are focused on Infections in Immunocompromised Hosts. He is a member of the Board of Directors for CAHR (Canadian Association for HIV Research) and President Elect for CFID (Canadian Foundation of Infectious Diseases). 


Learning Objectives:

  1. Review the epidemiology of invasive mold infections
  2. Examine the classification of invasive mold Infections and the role of new diagnostics
  3. Discuss illustrative cases
  4. Identify treatment and outcomes in invasive mold infections

 

This webinar is sponsored by  


October 14, 2020
9:00am PT/12:00pm ET

TBF conditioning, Haplo Transplants and Eltrombopag for Post-Transplant Cytopenia

Andrea BacigalupoMD

Speaker Biography: 

Dr.Bacigalupo has been the Head of Hematology at the San Martino Hospital Genova Italy (1990-2014) and then at Gemelli- Catholic University Rome (2015-2019). He has been involved in stem cell transplants since 1976, and has played an active role in the European Group for Blood and Marrow Transplants (EBMT) since 1977. He was Secretary of EBMT 1982-1986, chairperson of the SAA WP 1984-1990 and President of EBMT 1998-2002. He has conducted several prospective clinical trials in patients with aplastic anemia and in patients undergoing allogeneic transplants: in particular he has been the principal investigator of several prospective randomized studies in the field of GvHD. His main interests are bone marrow failure, GvHD and related complications. He is a member of several national and international hematology societies. He is Associate Editor of the journal Bone Marrow Transplantation and Biology of Blood and Marrow Transplantation and has published over 600 articles in peer-reviewed journals. His H index is 81. 


Learning Objectives:

  1. Understand TBF with BU-FLU in AML
  2. Understand TBF with BU-FLU/ FLU MEL/ FLU THIO in Myelofibrosis
  3. Review Haploidentical transplants with TBF: an update on 650 patients
  4. Review Eltrombopag for post-transplant cytopenia
  5. Understand combining PTCY and ATG for GvHD prophylaxis

 

This webinar is sponsored by 


October 28, 2020
12:00pm PT/3:00pm ET
CME Credit Hours: 1.0
 

The Role of Autologous Stem Cell Transplant in Myeloma in 2020

Donna Reece, MD (Princess Margaret Hospital, Toronto, ON)

Learning Objectives:
1.     To understand the role of ASCT in the era of newer anti-myeloma treatments, including immunotherapy.
2.     To discuss the use of post-ASCT treatment, with a focus on options for maintenance therapy.
3.     To review strategies for improving the outcome of ASCT in high-risk myeloma patients.

 

 

This webinar is sponsored by an unrestricted educational grant from 


November 4, 2020
9:00am PT/12:00pm ET


Management of CMV: What’s New, What’s Innovative, What Does the Future Hold?


Alissa Wright
MD (Vancouver General Hospital, St Paul’s Hospital, Vancouver Coastal Health, Vancouver, BC)
Jean-Sébastien DelisleMD, FRCPC, PhD (Hôpital Maisonneuve-Rosemont, Montreal, Québec)
Donald VinhMD, FRCPC, FACP (Department of Medicine, Faculty of Medicine, McGill University, Montreal, Québec) 

Learning Objectives: 
1. Review and evaluate new approaches on the management of CMV

 

 

This webinar is sponsored by  


November 18, 2020
9:00am PT/12:00pm ET

CAR-T in Diffuse Large B-Cell Lymphoma: Who and When?

Isabelle Fleury, MD (Hôpital Maisonneuve-Rosemont, Montreal, QC)

Learning Objectives:

After completing this program, participants will be able to:

  1. Assess current data on available anti-CD19 CAR-T in diffuse large B-cell lymphoma 
  2. Discuss referral considerations 
  3. Describe the selection process for CAR- T candidates 


This webinar is sponsored by  


November 25, 2020
12:00pm PT/3:00pm ET
CME Credit Hours: 1.0

Engineered Immune Effector Cells for Hematologic Malignancies

Kevin Hay, MD, MSc, FRCPC (BC Cancer Agency, Vancouver, BC)
 
Learning Objectives:
TBA


This webinar is sponsored by an unrestricted educational grant from 


 

This website is sponsored by an 
unrestricted educational grant from: